Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Chips and ships: Philips cuts outlook as supply chain problems grow

Published 10/18/2021, 01:28 AM
Updated 10/18/2021, 10:37 AM
© Reuters. FILE PHOTO: Dutch technology company Philips' logo is seen at the company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier

By Bart H. Meijer

AMSTERDAM (Reuters) - Dutch health technology company Philips on Monday cut its outlook for sales and profit growth this year and said the global supply chain problems that added to its growing list of worries in the third quarter would likely intensify.

Amsterdam-based Philips said comparable sales dropped 7.6% in the July-September period to 4.2 billion euros ($4.9 billion) as a shortage of electronic components such as memory chips and a lack of shipping containers hampered production and delivery.

"It's chips and ships", Chief Executive Frans van Houten told Reuters in a telephone interview.

Memory chip producers were not able to keep up with Philips' increased demand, Van Houten said, with orders for its products ranging from electric toothbrushes to patient monitoring systems rising 17% last quarter.

Ships transporting Philips' products were also backed up in ports worldwide as international trade rapidly recovered from the COVID-19 induced slump.

"We expect the port congestion to be temporary, while it could take until the second half of next year to get the shortage of chips under control", Van Houten said.

The impact of the supply chain problems will likely increase to 200 million euros in missed sales in the final quarter of 2021, the CEO said, up from 150 million euros in the third quarter.

Although the issues will probably still hit sales into 2022, Van Houten said he expected growth to return in the course of next year.

RECALL BITES

Philips shares fell almost 1% in early trading in Amsterdam, having already lost around a fifth of their value since the company recalled millions of respiratory devices in June.

It has set aside 500 million euros to repair or replace the popular machines used mainly for the treatment of sleep apnea.

The amount does not, however, cover the possible costs of litigation, with Philips facing more than a hundred class action suits from worried patients, some of whom have said degrading foam in the devices could cause cancer or other health issues.

Van Houten said it was still too early to estimate the costs of litigation, as Philips was working with experts to determine the actual health risks from the degrading foam, something that wasn't expected to be known until some point next year.

© Reuters. FILE PHOTO: Dutch technology company Philips' logo is seen at the company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier

The recall and supply chain problems pushed adjusted earnings before interest, taxes and amortisation (EBITA) down 25% in the third quarter to 512 million euros, slightly above analysts' expectations.

($1 = 0.8639 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.